Background: Black and Hispanic adults in the United States face a disproportionately high burden of cardiovascular disease (CVD). Digital health literacy (DHL) may influence CVD prevention and management, yet its role in these populations is not well understood. Objective: To examine associations between DHL and cardiovascular-related lifestyle behaviors, CVD, and CVD risk factors among Black and Hispanic adults. Methods: This was an exploratory analysis of survey data from a cross-sectional study among adults in Maryland, Virginia, and Washington, D.C. (March–June 2024). DHL was measured using items from the Digital Health Literacy Inventory and outcomes included self-reported CVD/risk factor diagnoses and lifestyle behaviors (physical activity, fruit-, vegetable-, and sugar-sweetened beverage [SSB] intake). Multivariable regression models were used to assess associations, adjusting for sociodemographic and health literacy factors. Results: Among 1,221 participants, the mean (SD) age was 44 (16) years; most were female (64%), insured (87%), non-Hispanic (69%), and identified as Black/African American (64%). Higher DHL was associated with greater vegetable intake (IRR =1.08, 95% CI=1.01–1.15). Contrary to our hypothesis, DHL was positively associated with SSB consumption (IRR=1.13, 95% CI=1.10–1.25). DHL showed a significant non-linear association with fruit intake. No significant associations were observed with CVD or its risk factors. Conclusions: The relationship between DHL and cardiovascular-protective behaviors was mixed, suggesting that DHL may not be sufficient to promote consistent health-protective behaviors. Findings highlight the need for interventions that strengthen DHL while also addressing broader contextual and structural factors such as targeted digital marketing of unhealthy food and beverages, as well as environmental barriers. Longitudinal and experimental studies are needed to clarify causal pathways and inform equitable CVD prevention strategies.
Randomized controlled trial to evaluate an app-based multimodal digital intervention for people with type 2 diabetes in comparison to a placebo app
IntroductionThis multi-center, parallel-group randomized controlled trial evaluated the app-based intervention mebix, developed by Vision2b GmbH in Germany, for people with type 2 diabetes compared to



